Dose Escalating and Safety Trial of Metformin With Induction Chemotherapy in Lymphoblastic Leukemia

Clinical Trial

Offered by: Nemours Children's Health, Jacksonville
Location: Jacksonville, Fla.

Trial Name

A Phase I Window, Dose Escalating and Safety Trial of Metformin in Combination With Induction Chemotherapy in Relapsed Refractory Acute Lymphoblastic Leukemia: Metformin With Induction Chemotherapy of Vincristine, Dexamethasone, Doxorubicin, and PEG-Aspar

What is the trial about?

A research study of a drug called Metformin in combination with standard chemotherapy for the treatment of patients with relapsed or refractory solid tumors.

Who can participate?

Male or female age 1-30 years at initial diagnosis.

What is involved?

Length of study is 6 months. Standard cancer care including medical history, physical exam, blood work, urine pregnancy test, ECG or MUGA, bone marrow aspirate, and/or biopsy.

Contact Nemours Children's Clinical Trials

Trial Name: A Phase I Window, Dose Escalating and Safety Trial of Metformin in Combination With Induction Chemotherapy in Relapsed Refractory Acute Lymphoblastic Leukemia: Metformin With Induction Chemotherapy of Vincristine, Dexamethasone, Doxorubicin, and PEG-Aspar

IRB# 241620

Is a Clinical Trial Right for Your Child?

Learn more about clinical trials and get answers to questions you might have.

Two researchers in a lab wearing coats and gloves, one looks into a microscope.